Patents by Inventor Marie-Ange DEMOITIE

Marie-Ange DEMOITIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
    Publication number: 20210386846
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for inducing an immune response against mycobacterial infections or disease comprising (i) at least one administration of a polypeptide Rv1196 related antigen and at least one administration of an adenovirus encoding a Rv1196 related antigen or (ii) at least one administration of a polypeptide Rv0125 related antigen and at least one administration of an adenovirus encoding a Rv0125 related antigen. Associated compositions, adenoviral constructs and polynucleotide sequences are also provided.
    Type: Application
    Filed: August 9, 2021
    Publication date: December 16, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marie-Ange DEMOITIÉ, Marie-Noëlle DONNER, Nadia OUAKED
  • Methods for inducing an immune response
    Patent number: 11110159
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for inducing an immune response against mycobacterial infections or disease comprising (i) at least one administration of a polypeptide Rv1196 related antigen and at least one administration of an adenovirus encoding a Rv1196 related antigen or (ii) at least one administration of a polypeptide Rv0125 related antigen and at least one administration of an adenovirus encoding a Rv0125 related antigen. Associated compositions, adenoviral constructs and polynucleotide sequences are also provided.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: September 7, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Marie-Ange Demoitie, Marie-Noelle Renelle Donner, Nadia Ouaked
  • Methods for inducing an immune response
    Patent number: 10688168
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition comprising an M72 related antigen and wherein a subsequent administration is delayed.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: June 23, 2020
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: William Ripley Ballou, Jr., Marie-Ange Demoitie, Marie-Noelle Renelle Donner, Nadia Ouaked, Stephane Theophile Temmerman
  • NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
    Publication number: 20180250375
    Abstract: The present invention relates to methods for inducing an immune response, in particular methods for inducing an immune response against mycobacterial infections or disease comprising (i) at least one administration of a polypeptide Rv1196 related antigen and at least one administration of an adenovirus encoding a Rv1196 related antigen or (ii) at least one administration of a polypeptide Rv0125 related antigen and at least one administration of an adenovirus encoding a Rv0125 related antigen. Associated compositions, adenoviral constructs and polynucleotide sequences are also provided.
    Type: Application
    Filed: July 25, 2016
    Publication date: September 6, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Marie-Ange DEMOITIE, Marie-Noelle Renelle DONNER, Nadia OUAKED
  • NOVEL METHODS FOR INDUCING AN IMMUNE RESPONSE
    Publication number: 20170112914
    Abstract: Methods and uses are provided for inducing an immune response comprising at least two administrations of an immunogenic composition comprising an M72 related antigen and wherein a subsequent administration is delayed.
    Type: Application
    Filed: April 2, 2015
    Publication date: April 27, 2017
    Inventors: William Ripley BALLOU, JR., Marie-Ange DEMOITIE, Marie-Noelle Renelle DONNER, Nadia OUAKED, Stephane Theophile TEMMERMAN